Company intelligence / Profile preview

Pul-Sar

Dubna, Moscow Oblast, Russiahaemoblock.ru ↗
Ownership
Private
Development stage
Other
01

Overview

Pul-Sar is a Russian medical device and biotechnology company specializing in the development and manufacture of innovative surgical products for hemostasis and lymphostasis. Operating as the production division of the Institute for Applied Medical Research (IAMR) in the Dubna Special Economic Zone, the company produces unique, clinically-proven solutions such as Haemoblock® and Lymphoblock®. Haemoblock® is a versatile local hemostatic agent containing a partial silver salt of polyacrylic acid that stops capillary and parenchymal bleeding, while Lymphoblock® is designed to prevent and manage lymphorrhea and seromas during major surgeries. These products are non-toxic, biocompatible, and widely utilized across hundreds of medical institutions globally.

Therapeutic areas
HematologyOther
Modalities
PolymerSmall molecule
Industry
Surgical Medical Devices
02

Partnerships

Institute for Applied Medical ResearchMenora Laboratories Research Center

Beyond the preview

Go deeper on Pul-Sar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pul-Sar.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call